Leadership Announcement: Dr. Daniel Chang
September 23, 2022
Dr. Daniel Chang has officially been announced by the University of Michigan as the Chair of the Department of Radiation Oncology, effective October 1, 2022.
ASTRO's Board of Directors
July 13, 2022
Dr. Iris Gibbs is newly elected to ASTRO's Board of Directors as the new Health Equity, Diversity and Inclusion (HEDI) Council Chair. In this position, she will be on the ASTRO board to make changes that will enhance heath equity for our patients and diversity to our specialty. Her impactful work will benefit not only our specialty but also oncology in general.
2022 ASTRO Fellow Designations
June 29, 2022
The American Society for Radiation Oncology (ASTRO) selected 27 distinguished members to receive the ASTRO Fellow (FASTRO) designation, including Stanford Radiation Oncology’s Mark K. Buyyounouski, MD, MS, Daniel T. Chang, MD, and Scott Soltys, MD. Congratulations!
The ASTRO Fellows program recognizes individuals who have made substantial contributions to the Society and to the field of radiation oncology through research, education, patient care and service to the field. Since its inception in 2006, the FASTRO designation has been awarded to just 421 of ASTRO’s 10,000 members worldwide.
NCI Mentored Clinical Scientist Research Career Development Award (K08)
August 15, 2022
Everett Moding, MD, PhD receives NCI K08 grant to support his career development and his research to develop biomarkers for patients with sarcomas who are treated with radiation therapy.
2022 Under One Umbrella-Women’s Cancer Innovation Award
August 1, 2022
Elizabeth Kidd, MD and Thomas Niedermayr, PhD receive 2022 Under One Umbrella-Women’s Cancer Innovation Award from the Stanford Women’s Cancer Center, Stanford Cancer Institute for their research proposal, “Faster is Better: Artificial Intelligence Optimized Cervical Cancer Brachytherapy Treatment Customization.”
2022 October Cancer Innovation Awards-Nodal Awards
August 1, 2022
Quynh-Thu Le, MD's proposal, “Neoadjuvant Pembrolizumab Cetuximab for Locally Advanced Betel Nut Induced Oral Cavity Cancer (NEO-CORAL) Phase II Clinical Trial”, was selected for funding as one of the Stanford Cancer Institute (SCI) 2022 October Cancer Innovation Awards-Nodal Awards.
Eradicating cancer and other diseases and eliminating cancer healthcare disparities by providing the highest quality, compassionate, cutting-edge, personalized radiation therapy.
2022 Stanford Health Care Medical Staff Awards:
Patient Experience Recognition Award
June 2, 2022
The Department of Radiation Oncology was recognized for delivering outstanding care and patient experience, which is based on direct patient feedback.
CyberKnife S7 Opening at Neurosciences Health Center
September 12, 2022
Stanford Medicine held a commemoration event on August 25, 2022, celebrating the new CyberKnife S7 at the Neuroscience Health Center. The addition of the S7 brings more seamless care to patients, with office visits, imaging, and procedures under one roof.
Speakers at the ribbon-cutting ceremony included Stanford Health Care leaders Alison Kerr and Sri Seshadri, and Stanford emeritus professor John Adler, MD, inventor of the CyberKnife. Other speakers included: Quynh Le, MD; Michael Lim, MD; Steven Chang, MD; and Scott Soltys, MD.
2022 Vizient Summit
September 22, 2022
Dr. Claire Baniel (PGY3 Rad Onc) and Dr. Melissa Frick (PGY5 Rad Onc) presented their work on “Implementing Environmentally Sustainable Practices in Outpatient Oncology Clinic” in a poster session at the Vizient annual conference this week. Vizient is the largest group purchasing organization in the US, and an organization that provides services and analytics on quality rankings, financial benchmarking and QI/process improvement work. The conference had 5000 attendees.
Training the next generation of compassionate leaders in radiation oncology, biology, and physics to address the healthcare needs of diverse populations through innovation, personalized patient care and research.